Skip to main content

Table 3 Relative abundance of fungal genera of colonic samples

From: Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Fungal taxa

Sham

SBS

GLP2.SBS

Eurotiomycetes.C

 Aspergillus.G

16.43 (6.48)

5.36 (1.61) **

9.14 (2.99)

 Penicillium.G

2.46 (1.07)

0.41 (0.16) **

1.75 (0.65) #

 Xerochrysium.G

0.00 (0.00–0.03)

0.31 (0.10–0.75) *

0.11 (0.03–0.50)

Saccharomycetes.C

 Wickerhamomyces.G

7.41 (2.27)

3.33 (1.62) *

4.12 (1.63)

 Debaryomyces.G

0.00 (0.00–0.17)

3.90 (2.43–7.56) **

0.30 (0.17–0.37) #

 Meyerozyma.G

4.66 (1.51)

13.51 (5.27) **

1.48 (0.26) ###

  1. Data were expressed as percentages of total sequences. For data passed normality test, one-way ANOVA and Tukey’s multiple comparisons test were used, and data were shown as mean (SD). Otherwise, Kruskal-Wallis and Dunn’s multiple comparisons test were used, and data were shown as median and IQR
  2. .C Class, G Genus
  3. *P < 0.05; **P < 0.01 compared with Sham group; #P < 0.05; ###P < 0.001 compared with SBS group